Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Changes in Shareholders??? Equity (Deficiency)

v3.7.0.1
Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity (Deficiency) - USD ($)
Total
Special Voting Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit [Member]
Comprehensive Income [Member]
Opening Balance at Mar. 31, 2016 $ 263,906 $ 0 $ 72,591 $ 11,801,146 $ (11,651,980) $ 42,149
Opening Balance (in shares) at Mar. 31, 2016   1 72,591,292      
Shares issued to acquire IMT 23,177,000 $ 0 $ 23,650 23,153,350 0 0
Shares issued to acquire IMT (in shares)   0 23,650,000      
Stock compensation acquired 2,582,890 $ 0 $ 0 2,582,890 0 0
Options exercised 18,166 $ 0 $ 110 18,056 0 0
Options exercised (in shares)   0 110,096      
Cashless exercise of warrants $ 43,562 $ 0 $ 51 43,511 0 0
Cashless exercise of warrants (in shares) 51,249 0 51,249      
Warrants exercised $ 40,195 $ 0 $ 175 40,020 0 0
Warrants exercised (in shares)   0 174,759      
Share compensation expense 1,001,950 $ 0 $ 217 1,001,733 0 0
Share compensation expense (in shares)   0 217,047      
Net loss for the period (3,936,574) $ 0 $ 0 0 (3,936,574) 0
Closing Balance at Mar. 31, 2017 23,191,095 $ 0 $ 96,794 38,640,706 (15,588,554) 42,149
Closing Balance (in shares) at Mar. 31, 2017   1 96,794,443      
Warrants exercised 1,125,038 $ 0 $ 5,000 1,120,038 0 0
Warrants exercised (in shares)   0 5,000,172      
Share compensation expense 251,048 $ 0 $ 0 251,048 0 0
Share compensation expense (in shares)   0 0      
Fair value adjustment for warrants exercised 204,790 $ 0 $ 0 204,790 0 0
Net loss for the period (2,245,322) 0 0 0 (2,245,322) 0
Closing Balance at Jun. 30, 2017 $ 22,526,649 $ 0 $ 101,794 $ 40,216,582 $ (17,833,876) $ 42,149
Closing Balance (in shares) at Jun. 30, 2017   1 101,794,615